0001123292-16-002938.txt : 20161103 0001123292-16-002938.hdr.sgml : 20161103 20161103160900 ACCESSION NUMBER: 0001123292-16-002938 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140312 FILED AS OF DATE: 20161103 DATE AS OF CHANGE: 20161103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Recro Pharma, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (484) 395-2400 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHURCHILL WINSTON J CENTRAL INDEX KEY: 0000923792 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 161971650 MAIL ADDRESS: STREET 1: C/O SCP PARTNERS STREET 2: SUITE 300, 1200 LIBERTY RIDGE DRIVE CITY: WAYNE STATE: PA ZIP: 19087 4/A 1 edgar.xml PRIMARY DOCUMENT X0306 4/A 2014-03-12 2014-03-13 0001588972 Recro Pharma, Inc. REPH 0000923792 CHURCHILL WINSTON J 490 LAPP ROAD MALVERN PA 19355 1 0 0 0 Common Stock 0 D Stock Option (right to buy) 8.00 2024-03-12 Common Stock 20000 20000 D On March 13, 2014, the reporting person filed a Form 4 mistakenly reporting (i) indirect beneficial ownership for 3,167,286 shares of common stock acquired in the conversion of Series A Redeemable Convertible Preferred Stock and 8% Convertible Promissory Notes and (ii) direct beneficial ownership of derivative securities from Series A Redeemable Convertible Preferred Stock and 8% Convertible Promissory Notes, which would convert into 1,121,548 and 2,045,738 shares of common stock, respectively, and were held by partnerships. As of March 13, 2014, the reporting person did not have indirect beneficial ownership of such shares, which were owned by SCP Vitalife Partners (Israel) II, L.P. and SCP Vitalife Partners II L.P. As of March 13, 2014, the reporting person only beneficially owned the stock option set forth in Table II above. The option vests in three equal installments on March 12, 2015, 2016, and 2017. /s/ Donna Nichols, Attorney-in-fact 2016-11-03